Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Combination of **diosgenin**, **vitamin D**, and **alpha-lactalbumin**. Diosgenin is a bioactive steroidal sapogenin found in plants, known for its pleiotropic effects including anti-inflammatory, antioxidant, cholesterol-lowering, antiatherosclerotic, and antithrombotic actions. Mechanistically, diosgenin modulates endothelial function, reduces adhesion molecule expression, inhibits NF-κB signaling, regulates lipid metabolism through promotion of ABCA1-mediated cholesterol efflux, and inhibits inflammatory cytokine production[1][2]. Vitamin D is a secosteroid involved in calcium homeostasis, bone health, immune modulation, and anti-inflammatory responses. Alpha-lactalbumin is a major whey protein that facilitates nutrient absorption, especially steroids and metals (such as vitamin D), supports immune modulation, acts as a prebiotic, and may improve gut microbiota and bioavailability of nutrients[3]. The combined formula may have synergistic effects in supporting cardiovascular health, metabolic function, inflammation reduction, and possibly improved bioavailability of its components via alpha-lactalbumin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on diosgenin + vitamin D + alpha-lactalbumin.